Company Data
Biomea Fusion Inc.
Ticker
BMEA
Current Price
$1.37 5.38%
Market Cap
$99.1M
Price Target
Refer to Report
Volume
1.5M
52wk Range
$0.8719 - $3.08
Overview
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company’s lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.